» Articles » PMID: 39062484

The Sweet Relationship Between the Endometrium and Protein Glycosylation

Overview
Journal Biomolecules
Publisher MDPI
Date 2024 Jul 27
PMID 39062484
Authors
Affiliations
Soon will be listed here.
Abstract

The endometrium is an important part of women's bodies for menstruation and pregnancy. Various proteins are widely expressed on the surface of endometrial cells, and glycosylation is an important post-translational modification of proteins. Glycosylation modification is closely related not only to endometrial receptivity but also to common diseases related to endometrial receptivity. Glycosylation can improve endometrial receptivity, promote embryo localization and trophoblast cell adhesion and invasion, and contribute to successful implantation. Two diseases related to endometrial receptivity include endometriosis and endometrial cancer. As a common benign disease in women, endometriosis is often accompanied by an increased menstrual volume, prolonged menstrual periods, progressive and aggravated dysmenorrhea, and may be accompanied by infertility. Protein glycosylation modification of the endometrial surface indicates the severity of the disease and may be an important pathogenesis of endometriosis. In cancer, glycosylation modifications on the surface of tumor cells can be a marker to distinguish the type and severity of endometrial cancer. This review highlights the role of protein glycosylation in embryo-maternal endometrial dialogue and explores its potential mechanisms in diseases related to endometrial receptivity, which could provide a new clinical approach for their diagnosis and treatment.

References
1.
Zheng Q, Zhang D, Yang Y, Cui X, Sun J, Liang C . MicroRNA-200c impairs uterine receptivity formation by targeting FUT4 and α1,3-fucosylation. Cell Death Differ. 2017; 24(12):2161-2172. PMC: 5686352. DOI: 10.1038/cdd.2017.136. View

2.
Wrona E, Potemski P, Sclafani F, Borowiec M . Leukemia Inhibitory Factor: A Potential Biomarker and Therapeutic Target in Pancreatic Cancer. Arch Immunol Ther Exp (Warsz). 2021; 69(1):2. PMC: 7907038. DOI: 10.1007/s00005-021-00605-w. View

3.
Foulk R, Zdravkovic T, Genbacev O, Prakobphol A . Expression of L-selectin ligand MECA-79 as a predictive marker of human uterine receptivity. J Assist Reprod Genet. 2007; 24(7):316-21. PMC: 3455010. DOI: 10.1007/s10815-007-9151-8. View

4.
Aghajanova L . Leukemia inhibitory factor and human embryo implantation. Ann N Y Acad Sci. 2005; 1034:176-83. DOI: 10.1196/annals.1335.020. View

5.
Arici A, Engin O, Attar E, Olive D . Modulation of leukemia inhibitory factor gene expression and protein biosynthesis in human endometrium. J Clin Endocrinol Metab. 1995; 80(6):1908-15. DOI: 10.1210/jcem.80.6.7775640. View